1. |
Kankova K, Vojtesek B, Valik D. The Rel/NFkappa B transcription factors and their biological functions [J]. Cas Lek Cesk, 2001; 140(6)∶163.
|
2. |
Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NFkappaB pathway in the treatment of inflammation and cancer [J]. J Clin Invest, 2001; 107(2)∶135.
|
3. |
Bohrer H, Qiu F, Zimmermann T, et al. Role of NFkappaB in the mortality of sepsis [J]. J Clin Invest, 1997; 100(5)∶972.
|
4. |
Han Y, Weinman S, Boldogh I, et al. Tumor necrosis factoralphainducible IkappaBalpha proteolysis mediated by cytosolic mcalpain. A mechanism parallel to the ubiquitinproteasome pathway for nuclear factorkappab activation [J]. J Biol Chem, 1999; 274(2)∶787.
|
5. |
Baeuerle PA. IkappaBNFkappaB structures: at the interface of inflammation control [J]. Cell, 1998; 95(6)∶729.
|
6. |
Wang P, Wu P, Siegel MI, et al. Interleukin (IL)10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL10 and IL4 suppress cytokine synthesis by different mechanisms [J]. J Biol Chem, 1995; 270(16)∶9558.
|
7. |
Maffia P, Ianaro A, Pisano B, et al. Beneficial effects of caffeic acid phenethyl ester in a rat model of vascular injury [J]. Br J Pharmacol, 2002; 136(3)∶353.
|
8. |
Ialenti A, Ianaro A, Maffia P, et al. Role of nuclear factorkappaB in a rat model of vascular injury [J]. Naunyn Schmiedebergs Arch Pharmacol, 2001; 364(4)∶343.
|
9. |
Hayashi K, Takahata H, Kitagawa N, et al. Nacetylcysteine inhibited nuclear factorkappaB expression and the intimal hyperplasia in rat carotid arterial injury [J]. Neurol Res, 2001; 23(7)∶731.
|
10. |
Aronson D. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure [J]. Med Hypotheses, 2002; 59(3)∶297.
|
11. |
李建军,李庚山,黄从新,等. 球囊损伤兔主动脉后核因子κB活性的动态变化 [J]. 中国动脉硬化杂志, 2001; 9(1)∶34.
|
12. |
Autieri MV, Yue TL, Ferstein GZ, et al. Antisense oligonucleotides to the p65 subunit of NFkB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries [J]. Biochem Biophys Res Commun, 1995; 213(3)∶827.
|
13. |
Maruyama I, Shigeta K, Miyahara H, et al. Thrombin activates NFkappa B through thrombin receptor and results in proliferation of vascular smooth muscle cells: role of thrombin in atherosclerosis and restenosis [J]. Ann N Y Acad Sci, 1997; 811∶429.
|
14. |
Meiners S, Laule M, Rother W, et al. Ubiquitinproteasome pathway as a new target for the prevention of restenosis [J]. Circulation, 2002; 105(4)∶483.
|
15. |
Ramana KV, Chandra D, Srivastava S, et al. Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells [J]. J Biol Chem, 2002; 277(35)∶32063.
|
16. |
Erl W, Hansson GK, de Martin R, et al. Nuclear factorkappa B regulates induction of apoptosis and inhibitor of apoptosis protein1 expression in vascular smooth muscle cells [J]. Circ Res, 1999; 84(6)∶668.
|
17. |
Ibe W, Bartels W, Lindemann S, et al. Involvement of PKC and NFkappaB in nitric oxide induced apoptosis in human coronary artery smooth muscle cells [J]. Cell Physiol Biochem, 2001; 11(5)∶231.
|
18. |
Conejo R, de Alvaro C, Benito M, et al. Insulin restores differentiation of Rastransformed C2C12 myoblasts by inducing NFkappaB through an AKT/P70S6K/p38MAPK pathway [J]. Oncogene, 2002; 21(23)∶3739.
|